Presentation
Vinorelbine plus capecitabine in a heavily pretreated HER2 negative metastatic breast cancer patient population: MCEPASTEBIN
American Society of Clinical Oncology (ASCO) Annual Meeting
(2018)
Disciplines
Publication Date
June, 2018
Location
Chicago, IL
Comments
Additional authors: Torres AE, Vogel CL, Ramdial J, Mahtani RL
Citation Information
Ana Cristina Sandoval Leon. "Vinorelbine plus capecitabine in a heavily pretreated HER2 negative metastatic breast cancer patient population: MCEPASTEBIN" American Society of Clinical Oncology (ASCO) Annual Meeting (2018) Available at: http://works.bepress.com/anacristina-sandovalleon/6/